Drugs News and Research

RSS

AARP praises General Assembly for preserving critical health care program

Older adults increasingly feeling the pinch of the recession got a significant break from the Illinois General Assembly, as legislators overrode a partial veto from Gov. Quinn on Thursday, preserving a program aimed at helping Medicare beneficiaries afford prescription drugs.

31 Oct 2009

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.

31 Oct 2009

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

The U.S. Food and Drug Administration today sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients and a dietary ingredient.

31 Oct 2009

NCI awards $4.8M for project to measure all the proteins in the human body

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

31 Oct 2009

ATLANTA-France study of the CATANIA Coronary Stent announced

Physicians at more than 40 centers in France have joined a study of the CATANIA(TM) Coronary Stent with NanoThin Polyzene®-F manufactured by CeloNova BioSciences. With Professor Emmanuel Teiger and Doctor Paul Barragan as co-Principal Investigators, the researchers today announced the Assessment of The Latest Non-Thrombogenic Angioplasty (ATLANTA-France) stent study. Each center will enroll 50 patients with the first procedures expected in early November.

31 Oct 2009

Health industry stakeholders focus on pain, not gain

Businesses, including medical device makers, insurers and pharmaceutical companies are bracing for tax and fee provisions in the House health care reform bill.

30 Oct 2009

60 Plus Association calls upon Sen. Lieberman not to support any bill which cuts Medicare

Today, the 60 Plus Association released a new TV ad targeting Senator Joe Lieberman (D-Conn.). The ad features members of our Greatest Generation begging Sen. Lieberman not to cut Medicare to pay for health care reform. The :30 second TV ad will run in conjunction with a :60 second ad that began airing on Wednesday.

30 Oct 2009

State watch: Virginia's pharmacy for mentally ill, Michigan dental care lawsuit, Rhode Island insurers

In today's state watch, Virginia plans to close a pharmacy for the mentally ill, Medicaid patients in Michigan are suing over dental care and Rhode Island reports that insurers remain relatively healthy.

30 Oct 2009

NeoStem completes acquisition of China Biopharmaceuticals Holdings

NeoStem, Inc., announced today that the Company has completed the acquisition of China Biopharmaceuticals Holdings, Inc., a leading Chinese pharmaceutical company.

30 Oct 2009

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Mintel predicts increased sales of OTC drugs in upcoming months

Autumn has arrived in the northern hemisphere and with shades of yellow and orange comes a less-welcome visitor: cold and flu season. Made worse this year by the H1N1 (swine flu) pandemic, people around the world are flocking to drugstores and supermarkets to stock up on over-the-counter (OTC) medicine, says market research firm Mintel.

30 Oct 2009

Monash University physiologist honored with Life Scientist of the Year award

A Monash University physiologist, whose research into weight management, obesity and diabetes has led to significant medical breakthroughs and drug design, has been awarded one of the nation's top research honours.

30 Oct 2009

Antioxidants may hold the key in preventing severe flu-related lung damage

As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. In an article appearing in the November 2009 print issue of the FASEB Journal (http://www.fasebj.org) they show that antioxidants-the same substances found in plant-based foods-might hold the key in preventing the flu virus from wreaking havoc on our lungs.

30 Oct 2009

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors.

30 Oct 2009

TGen to secure emergency FDA approval for 2009 H1N1 flu test

The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.

30 Oct 2009

FDA and WebMD Health collaborate to provide increased access to consumer health information

The U.S. Food and Drug Administration and WebMD Health Corp. today announced an expansion of their partnership to provide increased access to FDA's consumer health information.

30 Oct 2009

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

30 Oct 2009

Researchers show Simvastatin prevents Parkinson's disease from progressing further

Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.

30 Oct 2009

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

Human Genome Sciences, Inc. today announced financial results for the quarter ended September 30, 2009, and provided highlights of recent key developments.

30 Oct 2009

Drugs News and Research

AARP praises General Assembly for preserving critical health care program

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

NCI awards $4.8M for project to measure all the proteins in the human body

ATLANTA-France study of the CATANIA Coronary Stent announced

Health industry stakeholders focus on pain, not gain

60 Plus Association calls upon Sen. Lieberman not to support any bill which cuts Medicare

State watch: Virginia's pharmacy for mentally ill, Michigan dental care lawsuit, Rhode Island insurers

NeoStem completes acquisition of China Biopharmaceuticals Holdings

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Eisai reports global Phase III study results of eribulin mesylate

Mintel predicts increased sales of OTC drugs in upcoming months

Monash University physiologist honored with Life Scientist of the Year award

Antioxidants may hold the key in preventing severe flu-related lung damage

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

TGen to secure emergency FDA approval for 2009 H1N1 flu test

FDA and WebMD Health collaborate to provide increased access to consumer health information

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers show Simvastatin prevents Parkinson's disease from progressing further

Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News